摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl (Z)-2-methoxy-3-(4-methoxyphenyl)acrylate | 1214260-75-9

中文名称
——
中文别名
——
英文名称
ethyl (Z)-2-methoxy-3-(4-methoxyphenyl)acrylate
英文别名
——
ethyl (Z)-2-methoxy-3-(4-methoxyphenyl)acrylate化学式
CAS
1214260-75-9
化学式
C13H16O4
mdl
——
分子量
236.268
InChiKey
FCFOXKRFOYMQIR-XFXZXTDPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.25
  • 重原子数:
    17.0
  • 可旋转键数:
    5.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    44.76
  • 氢给体数:
    0.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    ethyl (Z)-2-methoxy-3-(4-methoxyphenyl)acrylate 在 lithium aluminium tetrahydride 、 氯化铵 作用下, 以 乙醚 为溶剂, 生成
    参考文献:
    名称:
    New stereospecific synthesis of Tesaglitazar and Navaglitazar precursors
    摘要:
    A new synthetic route of to pharmaceutical intermediates (S)-1a-b and (S)-14 is reported. The reaction pathway is based on the baker's yeast-mediated reduction of the alpha-alkoxy cinnamaldehydes 9a-c to give the corresponding (S)-alcohols in good yields and excellent ee. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2009.10.027
  • 作为产物:
    描述:
    2-methoxy-3-(4-methoxyphenyl)-2-propenoic acid溴乙烷四丁基碘化铵potassium carbonate 作用下, 以 丙酮 为溶剂, 以95%的产率得到ethyl (Z)-2-methoxy-3-(4-methoxyphenyl)acrylate
    参考文献:
    名称:
    New stereospecific synthesis of Tesaglitazar and Navaglitazar precursors
    摘要:
    A new synthetic route of to pharmaceutical intermediates (S)-1a-b and (S)-14 is reported. The reaction pathway is based on the baker's yeast-mediated reduction of the alpha-alkoxy cinnamaldehydes 9a-c to give the corresponding (S)-alcohols in good yields and excellent ee. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2009.10.027
点击查看最新优质反应信息

文献信息

  • Stereoselective β‐Arylation of Enol Ethers by a Pd‐Catalyzed Fujiwara‐Moritani Coupling of α‐Oxyacrylates
    作者:Iman Traboulsi、Mahmoud Hachem、Cédric Schneider、Christophe Hoarau
    DOI:10.1002/ejoc.202301074
    日期:2024.1.22
    Abstract

    Herein, Pd(II)‐catalyzed dehydrogenative Heck coupling of 2‐oxyacrylates with arenes for the stereocontrolled production of (Z)‐β‐arylated vinyl ethers is reported. This methodology offers a straightforward and step‐economical route to the synthesis of attractive β‐arylated α‐oxy α,β‐unsaturated carboxylates family which emerged as a relevant class of building blocks with different applications.

    摘要 本文报告了(II)催化的 2-氧丙烯酸酯与茴香的脱氢赫克偶联,用于立体控制生产(Z)-β-芳基化乙烯基醚。该方法为合成具有吸引力的 β-芳基化 α-氧基 α,β-不饱和羧酸盐家族提供了一条直接且步骤经济的途径。
  • Skin anti-ageing composition
    申请人:SHISEIDO COMPANY LIMITED
    公开号:EP0688559A1
    公开(公告)日:1995-12-27
    An anti-aging preparation for cutaneous application which prevents cutaneous aging, a collagen cross-linking inhibitory preparation for cutaneous application which inhibits collagen cross-linking occurring predominantly in the dermis to maintain skin elasticity and to prevent wrinkles or sagging, and an anti-UV preparation for cutaneous application which protects the skin from bad influences of excessive ultraviolet rays of sunlight are disclosed. The preparations contain one or two of aminoethyl compounds represented by formula (I):         NH₂CH₂CH₂X   (I) wherein X represents -SO₂H or -SO₂SH, and preferably containing at least one ultraviolet protective agent.
    本发明公开了一种用于皮肤应用的抗衰老制剂,可防止皮肤老化;一种用于皮肤应用的胶原交联抑制制剂,可抑制主要发生在真皮层的胶原交联,以保持皮肤弹性并防止皱纹或松弛;以及一种用于皮肤应用的抗紫外线制剂,可保护皮肤免受过度阳光紫外线的不良影响。这些制剂含有一种或两种由式(I)代表的基乙基化合物: NH₂CH₂CH₂X (I) 其中 X 代表-SO₂H 或-SO₂SH、 最好含有至少一种紫外线防护剂。
  • Anti-aging cosmetic composition
    申请人:SHISEIDO COMPANY LIMITED
    公开号:EP0797984A2
    公开(公告)日:1997-10-01
    An anti-aging cosmetic composition in which is blended an enzymolyzed substance obtained by treating by one or more enzymes an alkali extract of a hypoallergenic rice obtained by treating rice in advance with a proteinase and, preferably, a UV protective agent.
    一种抗衰老化妆品组合物,其中掺入了一种酶解物质,这种酶解物质是通过一种或多种酶处理低过敏性大米的碱提取物而获得的,这种低过敏性大米是通过事先用蛋白酶处理大米而获得的,最好还掺入了一种紫外线防护剂。
  • AGENTS PROMOTING LAMININ PRODUCTION IN SKIN CELLS
    申请人:SHISEIDO COMPANY LIMITED
    公开号:EP1066816A1
    公开(公告)日:2001-01-10
    Disclosed are compositions for promoting the production of laminin 5 in epidermic cells which contain a lysophospholipid having a C14-22 fatty acid residue or a preparation derived from soybeans as an active ingredient and which can be used in the fields of cosmetics and dermatology. These compositions may be used especially for the purpose of potentiating the skin.
    本发明公开了用于促进表皮细胞产生层粘连蛋白 5 的组合物,该组合物含有一种具有 C14-22 脂肪酸残基的溶血磷脂或一种从大豆中提取的制剂作为活性成分,可用于化妆品和皮肤病学领域。这些组合物尤其可用于增强皮肤的功效。
  • AGENTS PROMOTING THE FORMATION OF SKIN BASEMENT MEMBRANE, AGENTS PROMOTING THE FORMATION OF ARTIFICIAL SKIN AND PROCESS FOR PRODUCING ARTIFICIAL SKIN
    申请人:SHISEIDO COMPANY LIMITED
    公开号:EP1180371A1
    公开(公告)日:2002-02-20
    The present invention discloses an artificial skin formation promoting agent and skin basement membrane stabilizing agent comprising matrix metalloproteinase inhibitor or matrix metalloproteinase inhibitor and matrix protein production promoting agent; as well as a production method of artificial skin comprising adding matrix metalloproteinase inhibitor or matrix metalloproteinase inhibitor and matrix protein production promoting agent to an artificial skin formation medium.
    本发明公开了一种人工皮肤形成促进剂和皮肤基底膜稳定剂,包括基质属蛋白酶抑制剂或基质属蛋白酶抑制剂和基质蛋白生成促进剂;以及一种人工皮肤的生产方法,包括在人工皮肤形成介质中加入基质属蛋白酶抑制剂或基质属蛋白酶抑制剂和基质蛋白生成促进剂
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫